Goumas K - Search Results

1

Characteristics of Contents of Lower intestine in the 65-74 Years of Age Range Could Impact the Performance of Safe and Efficacious Modified Release Products.

Vertzoni M, Sulaiman S, Goumas K, Kersten E, Anlahr J, Muenster U, Reppas C. Vertzoni M, et al. Among authors: goumas k. J Pharm Sci. 2021 Jan;110(1):251-258. doi: 10.1016/j.xphs.2020.10.029. Epub 2020 Oct 21. J Pharm Sci. 2021. PMID: 33096137

2

Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies.

Kalantzi L, Goumas K, Kalioras V, Abrahamsson B, Dressman JB, Reppas C. Kalantzi L, et al. Among authors: goumas k. Pharm Res. 2006 Jan;23(1):165-76. doi: 10.1007/s11095-005-8476-1. Epub 2006 Dec 1. Pharm Res. 2006. PMID: 16308672 Clinical Trial.

3

Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.

Kalantzi L, Persson E, Polentarutti B, Abrahamsson B, Goumas K, Dressman JB, Reppas C. Kalantzi L, et al. Among authors: goumas k. Pharm Res. 2006 Jun;23(6):1373-81. doi: 10.1007/s11095-006-0207-8. Epub 2006 May 25. Pharm Res. 2006. PMID: 16715357

4

Estimating drug solubility in the gastrointestinal tract.

Dressman JB, Vertzoni M, Goumas K, Reppas C. Dressman JB, et al. Among authors: goumas k. Adv Drug Deliv Rev. 2007 Jul 30;59(7):591-602. doi: 10.1016/j.addr.2007.05.009. Epub 2007 May 29. Adv Drug Deliv Rev. 2007. PMID: 17599644 Review.

5

Characterization of the contents of ascending colon to which drugs are exposed after oral administration to healthy adults.

Diakidou A, Vertzoni M, Goumas K, Söderlind E, Abrahamsson B, Dressman J, Reppas C. Diakidou A, et al. Among authors: goumas k. Pharm Res. 2009 Sep;26(9):2141-51. doi: 10.1007/s11095-009-9927-x. Epub 2009 Jul 2. Pharm Res. 2009. PMID: 19572187

6

Characterization of the ascending colon fluids in ulcerative colitis.

Vertzoni M, Goumas K, Söderlind E, Abrahamsson B, Dressman JB, Poulou A, Reppas C. Vertzoni M, et al. Among authors: goumas k. Pharm Res. 2010 Aug;27(8):1620-6. doi: 10.1007/s11095-010-0158-y. Epub 2010 Apr 29. Pharm Res. 2010. PMID: 20428929

7

Degradation kinetics of metronidazole and olsalazine by bacteria in ascending colon and in feces of healthy adults.

Vertzoni M, Carlsson A, Abrahamsson B, Goumas K, Reppas C. Vertzoni M, et al. Among authors: goumas k. Int J Pharm. 2011 Jul 15;413(1-2):81-6. doi: 10.1016/j.ijpharm.2011.04.028. Epub 2011 Apr 22. Int J Pharm. 2011. PMID: 21540091

8

Precipitation in and supersaturation of contents of the upper small intestine after administration of two weak bases to fasted adults.

Psachoulias D, Vertzoni M, Goumas K, Kalioras V, Beato S, Butler J, Reppas C. Psachoulias D, et al. Among authors: goumas k. Pharm Res. 2011 Dec;28(12):3145-58. doi: 10.1007/s11095-011-0506-6. Epub 2011 Jun 15. Pharm Res. 2011. PMID: 21674262

9

Identification of key factors affecting the oral absorption of salts of lipophilic weak acids: a case example.

Petrakis O, Vertzoni M, Angelou A, Kesisoglou F, Bentz K, Goumas K, Reppas C. Petrakis O, et al. Among authors: goumas k. J Pharm Pharmacol. 2015 Jan;67(1):56-67. doi: 10.1111/jphp.12320. Epub 2014 Sep 23. J Pharm Pharmacol. 2015. PMID: 25252222

10

Effectiveness of supersaturation promoting excipients on albendazole concentrations in upper gastrointestinal lumen of fasted healthy adults.

Kourentas A, Vertzoni M, Symillides M, Goumas K, Gibbon R, Butler J, Reppas C. Kourentas A, et al. Among authors: goumas k. Eur J Pharm Sci. 2016 Aug 25;91:11-9. doi: 10.1016/j.ejps.2016.05.013. Epub 2016 May 13. Eur J Pharm Sci. 2016. PMID: 27185297 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page